Shares of Otsuka Holdings Co., Ltd. – Unsponsored ADR (OTCMKTS:OTSKY – Get Free Report) gapped down before the market opened on Friday . The stock had previously closed at $35.06, but opened at $33.68. Otsuka shares last traded at $33.68, with a volume of 454 shares.
Wall Street Analysts Forecast Growth
A number of equities research analysts recently weighed in on the company. UBS Group raised Otsuka to a “hold” rating in a research report on Tuesday, January 27th. Zacks Research raised Otsuka from a “strong sell” rating to a “hold” rating in a research report on Tuesday, March 31st. Morgan Stanley raised Otsuka to an “overweight” rating in a report on Friday, January 23rd. Finally, The Goldman Sachs Group downgraded Otsuka from a “strong-buy” rating to a “strong sell” rating in a report on Friday, February 27th. One analyst has rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, Otsuka presently has an average rating of “Hold”.
View Our Latest Stock Report on Otsuka
Otsuka Stock Down 1.7%
About Otsuka
Otsuka Pharmaceutical Co, Ltd., trading in the U.S. under the ticker OTCMKTS:OTSKY, is a global healthcare company headquartered in Tokyo, Japan. The firm’s core activities span the development, manufacturing and marketing of prescription pharmaceuticals, consumer healthcare products and nutraceuticals. Otsuka focuses its research on areas such as neuroscience, cardiovascular and renal therapies, and oncology, aiming to bring innovative treatments to patients worldwide.
Founded in 1964 by Busaburo Otsuka as a subsidiary of the Otsuka Group, the company has grown into a diversified healthcare enterprise over more than five decades.
See Also
Receive News & Ratings for Otsuka Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Otsuka and related companies with MarketBeat.com's FREE daily email newsletter.
